Advertisement

Index by author

May 01, 1982; Volume 21,Issue 3

A

  1. Aguayo, L G

    1. Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects.
      L G Aguayo, J E Warnick, S Maayani, S D Glick, H Weinstein and E X Albuquerque
      Molecular Pharmacology May 1982, 21 (3) 637-647;

  2. Albuquerque, E X

    1. Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects.
      L G Aguayo, J E Warnick, S Maayani, S D Glick, H Weinstein and E X Albuquerque
      Molecular Pharmacology May 1982, 21 (3) 637-647;

  3. Alexander, R W

    1. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
      J J Mooney, W C Horne, R I Handin, J J Schildkraut and R W Alexander
      Molecular Pharmacology May 1982, 21 (3) 600-608;

B

  1. Barwick, J L

    1. Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents.
      D M Heuman, E J Gallagher, J L Barwick, N A Elshourbagy and P S Guzelian
      Molecular Pharmacology May 1982, 21 (3) 753-760;

  2. Bases, R

    1. Morphological transformation, DNA strand separation, and antinucleoside immunoreactivity following exposure of cells to intercalating drugs.
      S Neubort, D Liebeskind, F Mendez, F Elequin, K C Hsu and R Bases
      Molecular Pharmacology May 1982, 21 (3) 739-743;

  3. Beaulieu, D

    1. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
      D S Rosenblatt, V M Whitehead, N V Matiaszuk, A Pottier, M J Vuchich and D Beaulieu
      Molecular Pharmacology May 1982, 21 (3) 718-722;

  4. Bösterling, B

    1. Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids.
      J R Trudell, B Bösterling and A J Trevor
      Molecular Pharmacology May 1982, 21 (3) 710-717;

  5. Brent, D A

    1. The formation of diarachidonyl diglyceride by rat neutrophils.
      M I Siegel, R T McConnell, D A Brent, P Chandrasurin, R D Macfarlane and C J McNeal
      Molecular Pharmacology May 1982, 21 (3) 688-693;

  6. Bristow, M R

    1. Histamine-mediated adenylate cyclase stimulation in human myocardium.
      M R Bristow, R Cubicciotti, R Ginsburg, E B Stinson and C Johnson
      Molecular Pharmacology May 1982, 21 (3) 671-679;

  7. Bulger, W H

    1. beta-Diethylaminoethyl-2, 2-diphenylpentanoate (SKF 525-A)-mediated translocation of uterine estrogen receptor from the cytosolic to the nuclear compartment in isolated rat uteri.
      W H Bulger and D Kupfer
      Molecular Pharmacology May 1982, 21 (3) 533-537;

C

  1. Chandrasurin, P

    1. The formation of diarachidonyl diglyceride by rat neutrophils.
      M I Siegel, R T McConnell, D A Brent, P Chandrasurin, R D Macfarlane and C J McNeal
      Molecular Pharmacology May 1982, 21 (3) 688-693;

  2. Chao, H

    1. Neonatal imprinting and hepatic cytochrome P-450. Immunochemical evidence for the presence of a sex-dependent and neonatally imprinted form(s) of hepatic cytochrome P-450.
      H Chao and L W Chung
      Molecular Pharmacology May 1982, 21 (3) 744-752;

  3. Chatelain, P

    1. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
      M Waelbroeck, P Robberecht, P Chatelain and J Christophe
      Molecular Pharmacology May 1982, 21 (3) 581-588;
    2. Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy.
      P Robberecht, M Waelbroeck, M Claeys, A N Huu, P Chatelain and J Christophe
      Molecular Pharmacology May 1982, 21 (3) 589-593;

  4. Chen, H C

    1. Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor.
      Y Shimohigashi, T Costa, S Matsuura, H C Chen and D Rodbard
      Molecular Pharmacology May 1982, 21 (3) 558-563;

  5. Christophe, J

    1. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
      M Waelbroeck, P Robberecht, P Chatelain and J Christophe
      Molecular Pharmacology May 1982, 21 (3) 581-588;
    2. Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy.
      P Robberecht, M Waelbroeck, M Claeys, A N Huu, P Chatelain and J Christophe
      Molecular Pharmacology May 1982, 21 (3) 589-593;

  6. Chung, L W

    1. Neonatal imprinting and hepatic cytochrome P-450. Immunochemical evidence for the presence of a sex-dependent and neonatally imprinted form(s) of hepatic cytochrome P-450.
      H Chao and L W Chung
      Molecular Pharmacology May 1982, 21 (3) 744-752;

  7. Claeys, M

    1. Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy.
      P Robberecht, M Waelbroeck, M Claeys, A N Huu, P Chatelain and J Christophe
      Molecular Pharmacology May 1982, 21 (3) 589-593;

  8. Cobb, M H

    1. Structural and conformational properties of peptides interacting with the glutathione receptor of hydra.
      M H Cobb, W Heagy, J Danner, H M Lenhoff and G R Marshall
      Molecular Pharmacology May 1982, 21 (3) 629-636;

  9. Costa, T

    1. Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor.
      Y Shimohigashi, T Costa, S Matsuura, H C Chen and D Rodbard
      Molecular Pharmacology May 1982, 21 (3) 558-563;

  10. Cubicciotti, R

    1. Histamine-mediated adenylate cyclase stimulation in human myocardium.
      M R Bristow, R Cubicciotti, R Ginsburg, E B Stinson and C Johnson
      Molecular Pharmacology May 1982, 21 (3) 671-679;

D

  1. Daly, J W

    1. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.
      A M Siegl, J W Daly and J B Smith
      Molecular Pharmacology May 1982, 21 (3) 680-687;

  2. Daniels, C K

    1. Movement of free cholesterol from lipoproteins or lipid vesicles into erythrocytes. Acceleration by ethanol in vitro.
      C K Daniels and D B Goldstein
      Molecular Pharmacology May 1982, 21 (3) 694-700;

  3. Danner, J

    1. Structural and conformational properties of peptides interacting with the glutathione receptor of hydra.
      M H Cobb, W Heagy, J Danner, H M Lenhoff and G R Marshall
      Molecular Pharmacology May 1982, 21 (3) 629-636;

E

  1. Ehler, F J

    1. Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide.
      B Ringdahl, F J Ehler and D J Jenden
      Molecular Pharmacology May 1982, 21 (3) 594-599;

  2. Elequin, F

    1. Morphological transformation, DNA strand separation, and antinucleoside immunoreactivity following exposure of cells to intercalating drugs.
      S Neubort, D Liebeskind, F Mendez, F Elequin, K C Hsu and R Bases
      Molecular Pharmacology May 1982, 21 (3) 739-743;

  3. Elshourbagy, N A

    1. Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents.
      D M Heuman, E J Gallagher, J L Barwick, N A Elshourbagy and P S Guzelian
      Molecular Pharmacology May 1982, 21 (3) 753-760;

G

  1. Gallagher, E J

    1. Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents.
      D M Heuman, E J Gallagher, J L Barwick, N A Elshourbagy and P S Guzelian
      Molecular Pharmacology May 1982, 21 (3) 753-760;

  2. Ginsburg, R

    1. Histamine-mediated adenylate cyclase stimulation in human myocardium.
      M R Bristow, R Cubicciotti, R Ginsburg, E B Stinson and C Johnson
      Molecular Pharmacology May 1982, 21 (3) 671-679;

  3. Glick, S D

    1. Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects.
      L G Aguayo, J E Warnick, S Maayani, S D Glick, H Weinstein and E X Albuquerque
      Molecular Pharmacology May 1982, 21 (3) 637-647;

  4. Goldstein, D B

    1. Movement of free cholesterol from lipoproteins or lipid vesicles into erythrocytes. Acceleration by ethanol in vitro.
      C K Daniels and D B Goldstein
      Molecular Pharmacology May 1982, 21 (3) 694-700;

  5. Guzelian, P S

    1. Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents.
      D M Heuman, E J Gallagher, J L Barwick, N A Elshourbagy and P S Guzelian
      Molecular Pharmacology May 1982, 21 (3) 753-760;

H

  1. Handin, R I

    1. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
      J J Mooney, W C Horne, R I Handin, J J Schildkraut and R W Alexander
      Molecular Pharmacology May 1982, 21 (3) 600-608;

  2. Harbon, S

    1. The relationship between the carbachol stimulatory effect on cyclic GMP content and activation by fatty acid hydroperoxides of a soluble guanylate cyclase in the guinea pig myometrium.
      D Leiber and S Harbon
      Molecular Pharmacology May 1982, 21 (3) 654-663;

  3. Harden, T K

    1. Differential modification of the interaction of cardiac muscarinic cholinergic and beta-adrenergic receptors with a guanine nucleotide binding component(s).
      T K Harden, A G Scheer and M M Smith
      Molecular Pharmacology May 1982, 21 (3) 570-580;

  4. Heagy, W

    1. Structural and conformational properties of peptides interacting with the glutathione receptor of hydra.
      M H Cobb, W Heagy, J Danner, H M Lenhoff and G R Marshall
      Molecular Pharmacology May 1982, 21 (3) 629-636;

  5. Heuman, D M

    1. Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents.
      D M Heuman, E J Gallagher, J L Barwick, N A Elshourbagy and P S Guzelian
      Molecular Pharmacology May 1982, 21 (3) 753-760;

  6. Hirsch, J D

    1. Heterogeneity of brain benzodiazepine receptors demonstrated by [3H]propyl beta-carboline-3-carboxylate binding.
      J D Hirsch, R L Kochman and P R Sumner
      Molecular Pharmacology May 1982, 21 (3) 618-628;

  7. Horne, W C

    1. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
      J J Mooney, W C Horne, R I Handin, J J Schildkraut and R W Alexander
      Molecular Pharmacology May 1982, 21 (3) 600-608;

  8. Howlett, A C

    1. Stimulation of neuroblastoma adenylate cyclase by arachidonic acid metabolites.
      A C Howlett
      Molecular Pharmacology May 1982, 21 (3) 664-670;

  9. Hsu, K C

    1. Morphological transformation, DNA strand separation, and antinucleoside immunoreactivity following exposure of cells to intercalating drugs.
      S Neubort, D Liebeskind, F Mendez, F Elequin, K C Hsu and R Bases
      Molecular Pharmacology May 1982, 21 (3) 739-743;

  10. Huu, A N

    1. Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy.
      P Robberecht, M Waelbroeck, M Claeys, A N Huu, P Chatelain and J Christophe
      Molecular Pharmacology May 1982, 21 (3) 589-593;

J

  1. Jenden, D J

    1. Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide.
      B Ringdahl, F J Ehler and D J Jenden
      Molecular Pharmacology May 1982, 21 (3) 594-599;

  2. Johnson, C

    1. Histamine-mediated adenylate cyclase stimulation in human myocardium.
      M R Bristow, R Cubicciotti, R Ginsburg, E B Stinson and C Johnson
      Molecular Pharmacology May 1982, 21 (3) 671-679;

K

  1. Katada, T

    1. Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets.
      S Yamazaki, T Katada and M Ui
      Molecular Pharmacology May 1982, 21 (3) 648-653;

  2. Kochman, R L

    1. Heterogeneity of brain benzodiazepine receptors demonstrated by [3H]propyl beta-carboline-3-carboxylate binding.
      J D Hirsch, R L Kochman and P R Sumner
      Molecular Pharmacology May 1982, 21 (3) 618-628;

  3. Kouakou, Y

    1. The opiate receptor-binding interactions of opiate alkaloids and of an opioid peptide in rat brain membranes. Selection by manganese ions and by cholic acid (sodium salt) and minimalization of cross-reaction in vitro.
      Y Kouakou, J M Zajac, C Moisand and J C Meunier
      Molecular Pharmacology May 1982, 21 (3) 564-569;

  4. Kupfer, D

    1. beta-Diethylaminoethyl-2, 2-diphenylpentanoate (SKF 525-A)-mediated translocation of uterine estrogen receptor from the cytosolic to the nuclear compartment in isolated rat uteri.
      W H Bulger and D Kupfer
      Molecular Pharmacology May 1982, 21 (3) 533-537;

L

  1. Leiber, D

    1. The relationship between the carbachol stimulatory effect on cyclic GMP content and activation by fatty acid hydroperoxides of a soluble guanylate cyclase in the guinea pig myometrium.
      D Leiber and S Harbon
      Molecular Pharmacology May 1982, 21 (3) 654-663;

  2. Lenhoff, H M

    1. Structural and conformational properties of peptides interacting with the glutathione receptor of hydra.
      M H Cobb, W Heagy, J Danner, H M Lenhoff and G R Marshall
      Molecular Pharmacology May 1982, 21 (3) 629-636;

  3. Liebeskind, D

    1. Morphological transformation, DNA strand separation, and antinucleoside immunoreactivity following exposure of cells to intercalating drugs.
      S Neubort, D Liebeskind, F Mendez, F Elequin, K C Hsu and R Bases
      Molecular Pharmacology May 1982, 21 (3) 739-743;

  4. Limbird, L E

    1. Sodium ion modulates agonist and antagonist interactions with the human platelet alpha 2-adrenergic receptor in membrane and solubilized preparations.
      L E Limbird, J L Speck and S K Smith
      Molecular Pharmacology May 1982, 21 (3) 609-617;

M

  1. Maayani, S

    1. Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects.
      L G Aguayo, J E Warnick, S Maayani, S D Glick, H Weinstein and E X Albuquerque
      Molecular Pharmacology May 1982, 21 (3) 637-647;

  2. Macfarlane, R D

    1. The formation of diarachidonyl diglyceride by rat neutrophils.
      M I Siegel, R T McConnell, D A Brent, P Chandrasurin, R D Macfarlane and C J McNeal
      Molecular Pharmacology May 1982, 21 (3) 688-693;

  3. Marshall, G R

    1. Structural and conformational properties of peptides interacting with the glutathione receptor of hydra.
      M H Cobb, W Heagy, J Danner, H M Lenhoff and G R Marshall
      Molecular Pharmacology May 1982, 21 (3) 629-636;

  4. Matiaszuk, N V

    1. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
      D S Rosenblatt, V M Whitehead, N V Matiaszuk, A Pottier, M J Vuchich and D Beaulieu
      Molecular Pharmacology May 1982, 21 (3) 718-722;

  5. Matsuura, S

    1. Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor.
      Y Shimohigashi, T Costa, S Matsuura, H C Chen and D Rodbard
      Molecular Pharmacology May 1982, 21 (3) 558-563;

  6. McConnell, R T

    1. The formation of diarachidonyl diglyceride by rat neutrophils.
      M I Siegel, R T McConnell, D A Brent, P Chandrasurin, R D Macfarlane and C J McNeal
      Molecular Pharmacology May 1982, 21 (3) 688-693;

  7. McNeal, C J

    1. The formation of diarachidonyl diglyceride by rat neutrophils.
      M I Siegel, R T McConnell, D A Brent, P Chandrasurin, R D Macfarlane and C J McNeal
      Molecular Pharmacology May 1982, 21 (3) 688-693;

  8. Mendez, F

    1. Morphological transformation, DNA strand separation, and antinucleoside immunoreactivity following exposure of cells to intercalating drugs.
      S Neubort, D Liebeskind, F Mendez, F Elequin, K C Hsu and R Bases
      Molecular Pharmacology May 1982, 21 (3) 739-743;

  9. Meunier, J C

    1. The opiate receptor-binding interactions of opiate alkaloids and of an opioid peptide in rat brain membranes. Selection by manganese ions and by cholic acid (sodium salt) and minimalization of cross-reaction in vitro.
      Y Kouakou, J M Zajac, C Moisand and J C Meunier
      Molecular Pharmacology May 1982, 21 (3) 564-569;

  10. Moisand, C

    1. The opiate receptor-binding interactions of opiate alkaloids and of an opioid peptide in rat brain membranes. Selection by manganese ions and by cholic acid (sodium salt) and minimalization of cross-reaction in vitro.
      Y Kouakou, J M Zajac, C Moisand and J C Meunier
      Molecular Pharmacology May 1982, 21 (3) 564-569;

  11. Mooney, J J

    1. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
      J J Mooney, W C Horne, R I Handin, J J Schildkraut and R W Alexander
      Molecular Pharmacology May 1982, 21 (3) 600-608;

N

  1. Neubort, S

    1. Morphological transformation, DNA strand separation, and antinucleoside immunoreactivity following exposure of cells to intercalating drugs.
      S Neubort, D Liebeskind, F Mendez, F Elequin, K C Hsu and R Bases
      Molecular Pharmacology May 1982, 21 (3) 739-743;

  2. Novak, R F

    1. 1H Fourier transform nuclear magnetic resonance relaxation rate studies on the interaction of acetanilide with purified isozymes of rabbit liver microsomal cytochrome P-450 and with cytochrome b5.
      R F Novak and K P Vatsis
      Molecular Pharmacology May 1982, 21 (3) 701-709;

P

  1. Pottier, A

    1. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
      D S Rosenblatt, V M Whitehead, N V Matiaszuk, A Pottier, M J Vuchich and D Beaulieu
      Molecular Pharmacology May 1982, 21 (3) 718-722;

R

  1. Ringdahl, B

    1. Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide.
      B Ringdahl, F J Ehler and D J Jenden
      Molecular Pharmacology May 1982, 21 (3) 594-599;

  2. Robberecht, P

    1. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
      M Waelbroeck, P Robberecht, P Chatelain and J Christophe
      Molecular Pharmacology May 1982, 21 (3) 581-588;
    2. Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy.
      P Robberecht, M Waelbroeck, M Claeys, A N Huu, P Chatelain and J Christophe
      Molecular Pharmacology May 1982, 21 (3) 589-593;

  3. Rodbard, D

    1. Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor.
      Y Shimohigashi, T Costa, S Matsuura, H C Chen and D Rodbard
      Molecular Pharmacology May 1982, 21 (3) 558-563;

  4. Rosenblatt, D S

    1. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
      D S Rosenblatt, V M Whitehead, N V Matiaszuk, A Pottier, M J Vuchich and D Beaulieu
      Molecular Pharmacology May 1982, 21 (3) 718-722;

  5. Rothman, R B

    1. Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain.
      R B Rothman and T C Westfall
      Molecular Pharmacology May 1982, 21 (3) 538-547;
    2. Allosteric coupling between morphine and enkephalin receptors in vitro.
      R B Rothman and T C Westfall
      Molecular Pharmacology May 1982, 21 (3) 548-557;

S

  1. Scheer, A G

    1. Differential modification of the interaction of cardiac muscarinic cholinergic and beta-adrenergic receptors with a guanine nucleotide binding component(s).
      T K Harden, A G Scheer and M M Smith
      Molecular Pharmacology May 1982, 21 (3) 570-580;

  2. Schildkraut, J J

    1. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
      J J Mooney, W C Horne, R I Handin, J J Schildkraut and R W Alexander
      Molecular Pharmacology May 1982, 21 (3) 600-608;

  3. Shimohigashi, Y

    1. Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor.
      Y Shimohigashi, T Costa, S Matsuura, H C Chen and D Rodbard
      Molecular Pharmacology May 1982, 21 (3) 558-563;

  4. Siegel, M I

    1. The formation of diarachidonyl diglyceride by rat neutrophils.
      M I Siegel, R T McConnell, D A Brent, P Chandrasurin, R D Macfarlane and C J McNeal
      Molecular Pharmacology May 1982, 21 (3) 688-693;

  5. Siegl, A M

    1. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.
      A M Siegl, J W Daly and J B Smith
      Molecular Pharmacology May 1982, 21 (3) 680-687;

  6. Smith, J B

    1. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.
      A M Siegl, J W Daly and J B Smith
      Molecular Pharmacology May 1982, 21 (3) 680-687;

  7. Smith, M M

    1. Differential modification of the interaction of cardiac muscarinic cholinergic and beta-adrenergic receptors with a guanine nucleotide binding component(s).
      T K Harden, A G Scheer and M M Smith
      Molecular Pharmacology May 1982, 21 (3) 570-580;

  8. Smith, S K

    1. Sodium ion modulates agonist and antagonist interactions with the human platelet alpha 2-adrenergic receptor in membrane and solubilized preparations.
      L E Limbird, J L Speck and S K Smith
      Molecular Pharmacology May 1982, 21 (3) 609-617;

  9. Speck, J L

    1. Sodium ion modulates agonist and antagonist interactions with the human platelet alpha 2-adrenergic receptor in membrane and solubilized preparations.
      L E Limbird, J L Speck and S K Smith
      Molecular Pharmacology May 1982, 21 (3) 609-617;

  10. Stinson, E B

    1. Histamine-mediated adenylate cyclase stimulation in human myocardium.
      M R Bristow, R Cubicciotti, R Ginsburg, E B Stinson and C Johnson
      Molecular Pharmacology May 1982, 21 (3) 671-679;

  11. Sumner, P R

    1. Heterogeneity of brain benzodiazepine receptors demonstrated by [3H]propyl beta-carboline-3-carboxylate binding.
      J D Hirsch, R L Kochman and P R Sumner
      Molecular Pharmacology May 1982, 21 (3) 618-628;

T

  1. Tew, K D

    1. Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
      K D Tew and A L Wang
      Molecular Pharmacology May 1982, 21 (3) 729-738;

  2. Trevor, A J

    1. Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids.
      J R Trudell, B Bösterling and A J Trevor
      Molecular Pharmacology May 1982, 21 (3) 710-717;

  3. Trudell, J R

    1. Reductive metabolism of halothane by human and rabbit cytochrome P-450. Binding of 1-chloro-2,2,2-trifluoroethyl radical to phospholipids.
      J R Trudell, B Bösterling and A J Trevor
      Molecular Pharmacology May 1982, 21 (3) 710-717;

U

  1. Ui, M

    1. Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets.
      S Yamazaki, T Katada and M Ui
      Molecular Pharmacology May 1982, 21 (3) 648-653;

V

  1. Vatsis, K P

    1. 1H Fourier transform nuclear magnetic resonance relaxation rate studies on the interaction of acetanilide with purified isozymes of rabbit liver microsomal cytochrome P-450 and with cytochrome b5.
      R F Novak and K P Vatsis
      Molecular Pharmacology May 1982, 21 (3) 701-709;

  2. Vuchich, M J

    1. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
      D S Rosenblatt, V M Whitehead, N V Matiaszuk, A Pottier, M J Vuchich and D Beaulieu
      Molecular Pharmacology May 1982, 21 (3) 718-722;

W

  1. Waelbroeck, M

    1. Rat cardiac muscarinic receptors. I. Effects of guanine nucleotides on high- and low-affinity binding sites.
      M Waelbroeck, P Robberecht, P Chatelain and J Christophe
      Molecular Pharmacology May 1982, 21 (3) 581-588;
    2. Rat cardiac muscarinic receptors. II. Influence of thyroid status and cardiac hypertrophy.
      P Robberecht, M Waelbroeck, M Claeys, A N Huu, P Chatelain and J Christophe
      Molecular Pharmacology May 1982, 21 (3) 589-593;

  2. Wang, A L

    1. Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards.
      K D Tew and A L Wang
      Molecular Pharmacology May 1982, 21 (3) 729-738;

  3. Warnick, J E

    1. Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects.
      L G Aguayo, J E Warnick, S Maayani, S D Glick, H Weinstein and E X Albuquerque
      Molecular Pharmacology May 1982, 21 (3) 637-647;

  4. Washtien, W L

    1. Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells.
      W L Washtien
      Molecular Pharmacology May 1982, 21 (3) 723-728;

  5. Weinstein, H

    1. Site of action of phencyclidine. IV. Interaction of phencyclidine and its analogues on ionic channels of the electrically excitable membrane and nicotinic receptor: implications for behavioral effects.
      L G Aguayo, J E Warnick, S Maayani, S D Glick, H Weinstein and E X Albuquerque
      Molecular Pharmacology May 1982, 21 (3) 637-647;

  6. Westfall, T C

    1. Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain.
      R B Rothman and T C Westfall
      Molecular Pharmacology May 1982, 21 (3) 538-547;
    2. Allosteric coupling between morphine and enkephalin receptors in vitro.
      R B Rothman and T C Westfall
      Molecular Pharmacology May 1982, 21 (3) 548-557;

  7. Whitehead, V M

    1. Differential effects of folinic acid and glycine, adenosine, and thymidine as rescue agents in methotrexate-treated human cells in relation to the accumulation of methotrexate polyglutamates.
      D S Rosenblatt, V M Whitehead, N V Matiaszuk, A Pottier, M J Vuchich and D Beaulieu
      Molecular Pharmacology May 1982, 21 (3) 718-722;

Y

  1. Yamazaki, S

    1. Alpha 2-adrenergic inhibition of insulin secretion via interference with cyclic AMP generation in rat pancreatic islets.
      S Yamazaki, T Katada and M Ui
      Molecular Pharmacology May 1982, 21 (3) 648-653;

Z

  1. Zajac, J M

    1. The opiate receptor-binding interactions of opiate alkaloids and of an opioid peptide in rat brain membranes. Selection by manganese ions and by cholic acid (sodium salt) and minimalization of cross-reaction in vitro.
      Y Kouakou, J M Zajac, C Moisand and J C Meunier
      Molecular Pharmacology May 1982, 21 (3) 564-569;
Back to top

In this issue